baber/WOPTO huggingface dataset:
Patent AU-4225597-A (AU)
Title: An assembly comprising a plate-shaped floor member, an assembly comprising at least two spaced-apart sections and at least one floor member extending between said sections, as well as a floor member and a section suitable for such assemblies
Inventor: PRONK ARIE DIRK CORNELIS
IPC: E04C2/52
Filed: 1997-09-23
Abstract: An assembly comprising a plate-shaped floor member (2) provided with a plate (3) and at least two ribs (4) between which a trench (8) is present. At least one rib bounding the trench is provided with at least one passage (5), which extends from said trench to a side of the rib remote from said trench. The assembly furthermore comprises at least one conduit (9) present in the trench, which conduit extends through said passage. The ribs are present on the upper side of the plate, with a plate-shaped covering (7) being present on or between said ribs on a side remote from said plate.
Patent AU-4239193-A (AU)
Title: Anti-receptor agents to the vitamin B12/transcobalamin II receptor
Inventor: MORGAN ALTON CHARLES JR
IPC: C12N15/02
Filed: 1993-05-07
Abstract: There is disclosed anti-receptor and growth blocking agents to the vitamin B12/transcobalamin II receptor and binding sites. The anti-receptor and growth blocking agents antagonize or modulate the vitamin B12/transcobalamin II receptor or binding sites, causing cellular depletion of vitamin B12, thus preventing or inhibiting cell division or causing apoptosis. Anti-receptor and growth blocking agents of the present invention include proteins (such as antibodies and antibody derivatives), peptides and small organic molecules. In a preferred embodiment, the anti-receptor agent is an antibody to the vitamin B12/transcobalamin II receptor.
Patent AU-4966196-A (AU)
Title: Tibial prosthesis
Inventor: JOHNSON CHRIS E
IPC: A61F2/30
Filed: 1996-01-30
Abstract: A tibial prosthesis includes a tibial tray and a post extending therefrom for receiving one or more modular stems of differing sizes. The stem provides a closed socket that registers with the post. A wedge lock fit tightens the stem to the post upon assembly. The stem has a cylindrical section and a tapering section. Fins extend longitudinally from the proximal end to the distal end of the stem, tracking both the cylindrical and tapering portion thereof so that each of the fins tracks a uniform diameter section of the stem for a majority of its length. The tapering section of the stem is equal to about one third of its over all length, and defines the distal end of the stem. The fins are longitudinally placed about the stem exterior surface, and are generally parallel. Between the fins are U-shaped channels that are similarly longitudinally extending and generally parallel. The stem provides a central longitudinal axis. The fins and channels are parallel to the central longitudinal axis of the stem.
Patent AU-4993999-A (AU)
Title: Connector for airbag gas generator
Inventor: LITTLE PHILIP V
IPC: H01R13/70
Filed: 1999-07-14
Abstract: A connector for an automobile airbag gas generator assembly requires only a single operator action to establish both mechanical and electrical engagement with a mating socket connector and two independent operator actions to disengage the connector from the socket connector. An alternate embodiment of the connector present invention requires two independent operator actions to establish both mechanical and electrical engagement with a mating socket connector carrying a deflectable shorting clip and three independent operator actions to disengage from the socket connector. A further embodiment of the connector of the present invention requires two independent operator actions for both establishing and breaking mechanical and electrical engagement with a mating socket. An improved shorting clip design is also provided as well as keying modes for assuring proper mechanical connection.
Patent AU-5158499-A (AU)
Title: Method for producing expandable styrene polymers containing exfoliated graphite particles
Inventor: GLUCK GUISCARD
IPC: C08J9/20
Filed: 1999-07-12
Abstract: The invention relates to a process for the preparation of expandable able styrene polymers containing particles of graphite by polymerization merization of styrene in aqueous suspension in the presence of particles of graphite having a mass density of less than 1.8 g/cm3.
Patent AU-5164900-A (AU)
Title: Process for co-production of dialkyl carbonate and alkanediol
Inventor: CHANG CLARENCE DAYTON
IPC: C07C68/06
Filed: 2000-05-24
Abstract: A method is provided for co-producing dialkyl carbonate and alkanediol by reacting alkylene carbonate with alkanol in the presence of a zeolite catalyst which contains alkali metal, alkaline earth metal, or a combination thereof present in excess of a stoichiometric amount.
Patent AU-5264979-A (AU)
Title: Detergent compositions having textile softening properties
Inventor: CRISP PETER NORMAN
IPC: C11D3/12
Filed: 1979-11-08
Abstract: Laundry detergent compositions are provided which contain an effective textile softening agent which does not reduce their cleaning performance. The softening agent comprises a specified class of tertiary amines together with a smectite-type clay.
Patent AU-5353694-A (AU)
Title: Delivery device having encapsulated excipients
Inventor: THOMBRE AVINASH GOVIND
IPC: A61K9/00
Filed: 1993-10-13
Abstract: PCT No. PCT/US93/09582 Sec. 371 Date May 11, 1995 Sec. 102(e) Date May 11, 1995 PCT Filed Oct. 13, 1993 PCT Pub. No. WO94/12152 PCT Pub. Date Jun. 9, 1994An asymmetric membrane, osmotic, delivery device having coated macroparticulate solubility modifiers. The device comprises a beneficial agent, an osmagent, a coated macroparticulate solubility modifier and an asymmetric membrane that surrounds the device components. The device is useful for dispensing a beneficial agent to an aqueous environment of use. The coated macroparticles modify the solubility of the beneficial agent so that it's release can be controlled. The larger size of the solubility modifier macroparticles provides, for example, a longer release duration than would have been possible with a smaller size.
Patent AU-5409996-A (AU)
Title: Ha-2 antigenic peptide
Inventor: GOULMY ELS A J M
IPC: C12N5/08
Filed: 1996-04-25
Abstract: The present invention discloses the first peptide sequence of a so-called minor H antigen. The minor H antigens are associated with the Graft versus Host Disease. The peptide and its derivatives find many uses in bone marrow transplantation, organ transplantation and in the treatment of leukemia. The peptide and its derivatives can be incorporated in vaccines, in pharmaceutical formulations and they can be used in diagnostic test kits. The peptide is derived from the HA-2 minor antigen and has the sequence YXGEVXVSV, wherein X represents a leucine or an isoleucine residue. Both donors and recipients in bone marrow transplantation can be treated with the peptides, optionally in combination with other peptides, coupled to carriers, with suitable excipients and/or adjuvants.
Patent AU-5417794-A (AU)
Title: Electronic display and/or apparatus having such a display
Inventor: PEDERSEN KJELD
IPC: G02F1/133
Filed: 1993-10-26
Abstract: An electronic display (2) for displaying signs or the like, for example for use in an electronic apparatus (1) within a cabinet (4) and with a keyboard (3) or similar control means. Behind the display there is arranged a radiation-sensitive power generator, for example a solar cell or a solar cell panel. Between the display and the solar cell there is arranged a filter which ensures the desired transmission and reflection of incident radiation.
Patent AU-5601400-A (AU)
Title: Novel benzylidenecyanoacetates and a method for making benzylidenecyanoacetates
Inventor: RIGHETTINI ROBIN F
IPC: C07C255/23
Filed: 2000-06-08
Abstract: Benzylidenecyanoacetates having a structure represented bywherein each R4 and R5 is the same or different and is selected from alkoxy, alkyl or alkyl ether. These benzylidenecyanoacetates are liquid at room temperature, have low volatility and are odor free and, thus, are useful in formulating adhesives and coatings.There is also provided a method for making a benzylidenecyanoacetate having a structure represented by formula Bthe method including:(e) reacting an alkyl cyanoacetate with a benzaldehyde to produce an alkyl benzylidenecyanoacetate and then(f) reacting the resulting alkyl benzylidenecyanoacetate with a hydroxy-functional reactant to produce the benzylidenecyanoacetate of formula B,wherein R6 is an alkyl, alkoxy, alkyl ether or a polymer backbone residue moiety.
Patent AU-5716296-A (AU)
Title: Clearance measurement system
Inventor: HAASE WAYNE C
IPC: G01B7/14
Filed: 1996-04-25
Abstract: The measuring device of the invention uses a capacitor polarized by a continuous voltage and conditioned by a continuous charge amplifier, this charge amplifier having a high-band filter structure, preferably of the second order. The technology of the capacitor and the linking cable is coaxial. The tuning of the chain measurement is effected theoretically without needing standardization.
Patent AU-5731386-A (AU)
Title: 99mTc(III) myocardial imaging agents which are non-reducable in vivo
Inventor: DEUTSCH EDWARD A
IPC: C07F13/00
Filed: 1986-05-09
Abstract: A cationic <99m>Tc<III> myocardial imaging agent is disclosed which has a relatively negative redox potential. This prevents in vivo reduction of the Tc(III) to Tc(II). The redox potential of the Tc(III) is controlled by complexing the Tc with both hard and soft atoms. Preferably four of the atoms complexed to the Tc(III) are hard atoms such as nitrogen or oxygen and the remaining two are soft atoms such as phosphorous or arsenic. These imaging agents are particularly useful in imaging the human heart.
Patent AU-5834986-A (AU)
Title: PCM audio signal recording and/or reproducing apparatus
IPC: G11B20/10
Filed: 1986-06-04
Abstract: @ A PCM (pulse code modulated) audio signal recording and/or reproducing apparatus, operates with plural scanning periods, in which a rotary head (RD) scans obliquely a longitudinal direction of a tape (TP), and which are separated into a plurality of segment periods. A PCM audio signal is recorded on one channel of a plurality of track channels, formed by the alignment of respective segment tracks (34) which are scanned by the rotary head (RD) during the same segment period of each scanning period, and an identifying signal, indicative of the fact that the PCM audio signal is already recorded, is superimposed upon the PCM audio signal and recorded together on the track channel, whereby it becomes possible to easily identify whether or not the PCM audio signal is recorded on the plurality of track channels.
Patent AU-5887386-A (AU)
Title: Hemostatic adhesive bandage
Inventor: SAFERSTEIN LOWELL
IPC: A61F13/00
Filed: 1986-06-13
Abstract: Hemostatic adhesive bandages are disclosed wherein a very thin coating of a high molecular weight polyethylene oxide is applied to the surface of the perforated plastic film wound release cover of an adhesive bandage, in a manner compatible with commonly used high speed production techniques and equipment, which stop the bleeding faster when applied to minor cuts.
Patent AU-5918586-A (AU)
Title: Device and process for simultaneously winding several separate fibers on a rotating support
IPC: B65H54/20
Filed: 1986-06-24
Abstract: The installation comprises a spinnerette which receives a thermoplastic material, and a rotating spindle carrying a support or tube which ensures the drawing of the filaments from the spinnerette as well as the winding of the filaments. There is an assembly and a guide device and a traverse mechanism comprising a filament guide, which has an opening facing spindle which communicates with an internal guide zone with at least two slots. Pref. slots of the filament guide are regularly spaced on either side of a line through the centre of the yarn guide perpendicular to the axis of rotation of the spindle. The depth of the slots is different for the slots on one side of the guide. Device with slots is attached to a rod parallel to the axis of rotation by the intermediate of means which allows the regulation of the distance sepg. the guide from the preceeding zone. Mainly used in the mfr. of glass filaments, assures sepn. of individual filaments in subsequent unwinding.
Patent AU-5996886-A (AU)
Title: Method for the production of a macromolecular carrier loaded with a biologically active substance
Inventor: MASQUELIER MICHELE
IPC: A61K47/44
Filed: 1986-06-17
Abstract: PCT No. PCT/SE86/00291 Sec. 371 Date Feb. 12, 1987 Sec. 102(e) Date Feb. 12, 1987 PCT Filed Jun. 17, 1986 PCT Pub. No. WO86/07539 PCT Pub. Date Dec. 31, 1986.The invention relates to a method for the preparation of a carrier loaded with lipophilic biologically active substance based on reconstituted LDL (Low Density Lipoprotein), wherein (1) LDL is lyophilized in the presence of a protective agent; (2) the lyophilized LDL is extracted with an organic solvent; (3) the biologically active substance solubilized in a solvent is incubated with extracted LDL; the solvent is evaporated and the reconstituted LDL solubilized in an aqueous buffer; the non-incorporated biologically active substance is separated from the LDL-complex, characterized in that in step (1) the protective agent is a monosaccharide, a disaccharide, a water-soluble polysaccharide, a sugar alcohol or a mixture of these and in step (3) optionally the extract obtained during the extraction of the lyophilized LDL is mixed with the lipophilic biologically active substance solubilized in an organic solvent and this mixture is then incubated with the LDL. Preferred protective agents are sucrose, glucose and fructose. The reconstituted LDL obtained by the claimed process have properties similar to native LDL in vitro and in vivo.
Patent AU-6061180-A (AU)
Title: Calcium aluminium fluorosilicate glass powder
Inventor: SCHMITT W
IPC: C08L35/00
Filed: 1980-07-18
Abstract: A calcium aluminum fluorosilicate glass powder is disclosed which has average particle size of at least 0.5 microns, and is characterized in that the calcium in the surface of the powder's particles is depleted so that the quotient of the atomic ratio Si/Ca at the surface of the particles and the atomic ratio Si/Ca in the core region of the particles is at least 2.0, more preferably at least 3.0 and most preferably at least 4.0. The glass powder may be prepared by surface treating calcium aluminum fluorosilicate glass powder particles with an acid which forms calcium salts, washing the calcium salts off the treated particles and drying the washed particles. The glass powder has utility in self-hardening glass ionomer cements, such as dental or bone cements. Cements formed from the glass powder exhibit reduced periods of water sensitivity, while permitting sufficient time for processing.
Patent AU-6196986-A (AU)
Title: Process for purifying silver refinery slimes
Inventor: REEVES WILLIAM H
IPC: C22B3/00
Filed: 1986-07-29
Abstract: Gold sand resulting from the nitric acid treatment of silver refinery slimes is purified by washing with hydrochloric acid under controlled operating conditions. Platinum and other precious metals and impurities are selectively separated from the gold sand leaving a gold sand which is more efficiently refined.
Patent AU-6320499-A (AU)
Title: Method and apparatus for the storage of entomopathogenic nematodes
Inventor: BEDDING ROBIN ANTHONY
IPC: A01K67/033
Filed: 1999-09-28
Abstract: Third stage juvenile (J3) entomopathogenic nematodes are prepared for storage by being induced into a state of cryptobiosis. The induction of cryptobiosis is effected by mixing an aqueous cream of the J3 nematodes with anhydrous, small particles of non-fibrous cellulose. The cryptobiotic J3 nematodes are stored in a container, fitted with an attachment which maintains the water activity in the container at a required value. The attachment includes a rigid tube that connects the interior of the container with a chamber that is vented to ambient atmosphere by small apparatus. The chamber contains water-absorbent material saturated with water or with a saturated salt solution, and the tube contains an air-permeable plug. An alternative attachment comprises a plastic envelope as the chamber, one face of which is stuck to the wall of the container. Small aperatures in the face are aligned with apertures in the container wall. Small apertures in the other face connect the inside of the envelope to ambient atmosphere.
Patent AU-6382390-A (AU)
Title: Azabicyclo compounds
Inventor: JENKINS SARAH MARGARET
IPC: C07D487/08
Filed: 1990-10-05
Abstract: A compound of formula (I) or a pharmaceutically acceptable salt thereof: <CHEM> in which one of X and Y represents hydrogen and the other represents Z, where Z is a group <CHEM> in which Q represents a 3-membered divalent residue completing a 5-membered aromatic ring and comprises zero, one or two nitrogen atoms, Q being optionally C-substituted by a group R1 selected from halogen, CN, OR2, SR2, N(R2)2, NHCOR2, NHCOOCH3, NHCOOC2H5, NHOR2, N3, NHNH2, NO2, COR2, COR3, C2-4 alkenyl, C2-4 alkynyl, cyclopropyl or C1-2 alkyl optionally substituted with OR2, N(R2)2, SR2, CO2R2, CON(R2)2 or one, two or three halogen atoms, in which each R2 is independently hydrogen or C1-2 alkyl and R3 is OR2, NH2 or NHR2; r represents an integer of 2 or 3, s represents an integer of 1 or 2 and t represents 0 or 1; Ra and Rb each represent hydrogen or, when X is hydrogen, optionally together represent a bond; with the proviso that when Y is hydrogen s is 1.
Patent AU-6383186-A (AU)
Title: Process for the preparation of stabilized isosorbide-5-mononitrate tablets, being also of sustained release, and formulations thus obtained
Inventor: CALANCHI MASSIMO
IPC: C07D493/04
Filed: 1986-10-13
Abstract: The present invention relates to obtaining isosorbide-5-mononitrate tablets, being also of retard form, which are stable in time. Such embodiment is now possible after the discovery of the stabilizing activity of the polyvinylpyrrolidone with respect to the isosorbide-5-mononitrate with which it forms a solid solution. The use of PVP is essential so that the tablets can remain stable in time: the retard effect in turn can be obtained with the use of hydroxyalkylcelluloses.
Patent AU-6423690-A (AU)
Title: Syringe
Inventor: ROBB DARRYL GORDON
IPC: A61M5/50
Filed: 1990-09-17
Abstract: A safety syringe for preventing "needle stick" injury and/or reuse of the syringe. The syringe comprises a body, a plunger mounted within the body, connection means for connecting the plunger to a needle holder adapted in use to carry a needle at the end of an injection stroke of the plunger whereby subsequent retraction of the plunger withdraws the needle into a shielded position within the body. The syringe includes a braking means disposed between the body and the plunger to retard but not stop the withdrawal of the plunger and needle after the injection stroke. The needle holder includes a radially extending flange which engages with a complementary rib or groove on the syringe until the needle holder is engaged by a protuberance on the plunger. Engagement of the protuberance with the needle holder serves to deform the needle holder and to draw the flange radially inwardly out of contact with the complimentary rib or groove on the syringe thereby allowing the needle holder and any needle attached to it to be drawn into the body of the syringe.
Patent AU-6470999-A (AU)
Title: Compositions for the treatment and prevention of cardiovascular diseases
Inventor: BUCHHOLZ HERWIG
IPC: A23L33/15
Filed: 1999-10-13
Abstract: Compositions comprising one or more active ingredients and, optionally, one or more nutritional substances, solid, liquid and/or semiliquid excipients or auxiliaires, wherein the active ingredients consist of a) a <u>component A</u> consisting of one or more compounds selected from methyl and methylene donors, b) a <u>component B</u> consisting of one or more methyl transporters, and c) a <u>component C</u> consisting of one or more bioflavonoids are well-suited for the treatment and prevention of transmethylation disorders, preferably cardiovascular diseases such as atherogenic and thrombogenic diseases.
Patent AU-6611181-A (AU)
Title: Water-dispersible-hydrophobic dyes as labels in immunoassays
Inventor: GRIBNAU THOMAS CORNELIS JOSEPH
IPC: G01N33/536
Filed: 1981-01-09
Abstract: The present invention relates to a process for the qualitative and/or quantitative determination of an immunochemically reactive component, in which one or more labelled components are used, that are obtained by direct or indirect coupling of such a component or components to particles of an aqueous dispersion of a hydrophobic dye or pigment, or of polymer nuclei coated with such a dye or pigment. 
<??>During the reaction or after an adequate reaction time the nature and/or the quantity of the dye is determined in the test medium, or optionally after a separation of the bound and free labelled components in one of the fractions by methods known by themselves.
Patent AU-6736696-A (AU)
Title: Use of agonists or antagonists of p2 purinoceptors for the prevention of glutamate-evoked cytotoxicity
Inventor: VOLONTE CINZIA
IPC: A61P25/00
Filed: 1996-07-24
Abstract: This invention relates to the use of agonists or antagonists of P2 purinoceptors for the prevention of glutamate-evoked cytotoxicity and in particular use of Basilen Blue D-3G (Reactive Blue 2), Cibacron Blue 3GA and 5-adenylylimidodiphosphate (AMPPNP). In the presence of cytotoxic concentrations of glutamate, these compounds sustain cellular survival of central nervous system (CNS) neurons, such as for example postnatal rat cerebellar granule neurons.
Patent AU-6936396-A (AU)
Title: Detector and method for autoradiography
Inventor: FRASER GEORGE WILLIAM
IPC: G01T1/29
Filed: 1996-09-10
Abstract: There is disclosed an autoradiography system which includes an autoradiography sample, a substantially radioisotope free microchannel plate (MCP), and an MCP signal collection means, wherein the MCP directly measures beta particles from radioisotopes within the sample.
Patent AU-7102296-A (AU)
Title: Process for the preparation of manganese sulphide
Inventor: ENGSTROM ULF
IPC: C01G45/00
Filed: 1996-09-20
Abstract: The present invention concerns the preparation of a manganese sulphide by heating of particulate or agglomerate manganese sulphate to a temperature of at least 700  DEG C in the presence of at least one reduction agent.
Patent AU-7117891-A (AU)
Title: Therapeutic agent for diabetic gangrene
Inventor: SHIKANO MASAHIKO
IPC: C12N9/10
Filed: 1991-02-19
Abstract: An agent for the therapy of diabetic gangrene is described containing blood coagulation factor XIII as the active ingredient.
Patent AU-7206300-A (AU)
Title: Apparatus and process for transporting supplementary products
Inventor: MULLER ERWIN
IPC: B65H5/12
Filed: 2000-12-06
Abstract: The transporting device includes a holding unit (20a, 20b, 20c, 20d) which can be turned about an axis perpendicular to the circumferential track by means of a control device selectively during the transportation from the receiving point to the issuing point (A1, A2), leaving it in a turned position or turning it to a set angle for further processing.
Patent AU-7300394-A (AU)
Title: Vinyl ether compounds having additional functional groups other than vinyl ether groups and the use thereof in the formulation of curable compositions
Inventor: STEINMANN BETTINA
IPC: C08F2/46
Filed: 1994-09-15
Abstract: The invention relates to compounds with at least one vinyl ether group, which additionally have at least one further functional group, selected from acrylate, methacrylate, epoxide, alkenyl, cycloalkenyl and vinylaryl groups, in the molecule, compositions, in particular for stereolithography, containing these vinyl ether compounds and a process for the preparation of three-dimensional objects with the aid of the compositions.